Roche Wins Genentech With Raised $46.8B Offer

March 11, 2009

106

Roche Holding AG has struck a deal with Genentech Inc to buy all outstanding shares for $46.8 billion, or $95 each, ending a long pursuit of the U.S. biotech group and its lucrative cancer drugs.

*For more on this story,

read the full Reuters article.

Want more from the best local business newspaper in the country?

Sign-up for our FREE Daily eNews update to get the latest Orange County news delivered right to your inbox!

Would you like to subscribe to Orange County Business Journal?

One-Year for Only $99

Unlimited access to OCBJ.com
Daily OCBJ Updates delivered via email each weekday morning
Journal issues in both print and digital format
The annual Book of Lists: industry of Orange County's leading companies
Special Features: OC's Wealthiest, OC 500, Best Places to Work, Charity Event Guide, and many more!

PacSun Results Better Than Expected; Another Loss Projected

STEC Shares Soar on Outlook

staff-author

Roche Wins Genentech With Raised $46.8B Offer

Want more from the best local business newspaper in the country?

Would you like to subscribe to Orange County Business Journal?

Featured Articles

Vans Down 1% to $487M in Q4

Midday Stock Roundup: Xponential Up 8%

Medtronic Neuroscience Leader Brett Wall Announces Departure

Related Articles

Vans Down 1% to $487M in Q4

Midday Stock Roundup: Xponential Up 8%

Medtronic Neuroscience Leader Brett Wall Announces Departure

Defense Company Mach Industries Buys Exquadrum

Zov’s Remains as Enderle Center Gets Burnham-Ward Makeover

Advertise With Us

About Us

Subscriber Links

Other Journals